Media mentions

Get the latest on what’s new with Labviva

Nicholas Rioux of Labviva: On How Businesses Can Address Supply Chain Management With The Looming Tariff Changes

April 6, 2025
|
Authority Magazine

Empower lower-level decision makers to be responsive to shifts in the supply chain. It is commonplace to centralize decision-making higher up in the organization regarding supply chain management. This is historically due to prime supplier strategies where negotiations are best done in a consolidated format. By implementing better technologies throughout the supply chain and leveraging marketplace systems, decisions can be decentralized and pushed downstream. I have worked with companies throughout the life sciences space that have successfully tapped into the savings that this decentralization can create, and they have seen hard cost savings of around 20% over more centralized models. Those levels of savings can mitigate the impacts of tariffs and provide more options to work around them.

Strategies for Mitigating Supply Chain Risks in Life Sciences

January 22, 2025
|
Supply & Demand Chain Executive

The disruptions of recent years serve as a powerful reminder: a resilient supply chain is not just a competitive advantage—it’s a necessity for advancing global health.

Labviva Secures $25 Million Series B to Advance AI-Driven Procurement in Life Sciences

January 14, 2025
|
Biopharma Boardroom

Backed by 53 Stations and key investors, Labviva aims to revolutionize supply chain transparency and accelerate scientific innovation with cutting-edge artificial intelligence solutions.Backed by 53 Stations and key investors, Labviva aims to revolutionize supply chain transparency and accelerate scientific innovation with cutting-edge artificial intelligence solutions.

Labviva Secures $25M to Accelerate Product Development and Global Expansion

January 14, 2025
|
AI Insider

Labviva, an AI-powered procurement platform for life sciences, secured $25M in Series B funding led by 53 Stations, bringing its total funding to $55M, to drive product innovation, expand internationally, and enhance customer support.

Labviva raises $25M to boost AI-powered life sciences procurement platform

January 13, 2025
|
Silicon Angle

Labviva Inc., a startup offering an artificial intelligence procurement platform for life sciences, announced today that it has raised $25 million in new funding to accelerate product innovation, enhance marketing and customer support, and expand internationally.

Pritzker Organization's 53 Stations invests in lab procurement platform Labviva

January 13, 2025
|
Crain's Chicago Business

53 Stations, the venture-capital fund supported by The Pritzker Organization, led a $25 million Series B fundraising round for Labviva, a lab and life sciences procurement platform in Boston.

China Turns to Silicon Valley to Bolster Homegrown AI Firms

November 22, 2024
|
PYMNTS

Chinese tech giants are reportedly using Silicon Valley to recruit for their AI projects.

Experts Say AI’s Rapid Rise Masks Deep Flaws

November 11, 2024
|
PYMNTS

Artificial intelligence (AI) chatbots that dazzle millions with eloquent poetry and computer code are operating with fundamental gaps in their grasp of how the world works, according to new research from MIT.

Meet the BostInno 2024 Fire Awards honorees

October 8, 2024
|
BostInno

The Fire Awards is BostInno’s premier awards and events showcase. Every year, we recognize 50 companies, organizations or people that have had a banner year.

Keep up with the latest on Labviva

Sign up to receive updates on the latest in life sciences, AI, and procurement from the Labviva team.

By clicking Sign Up you're confirming that you agree with our Terms and Conditions.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.